TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 7 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q2 2014. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2015 | $2,327,000 | +4.9% | 106,394 | +15.9% | 0.15% | +6.9% |
| Q2 2015 | $2,218,000 | -3.1% | 91,793 | +0.3% | 0.14% | +4.3% |
| Q1 2015 | $2,288,000 | +26.9% | 91,495 | +5.8% | 0.14% | +25.5% |
| Q4 2014 | $1,803,000 | -13.7% | 86,511 | -10.0% | 0.11% | -14.1% |
| Q3 2014 | $2,090,000 | +13.6% | 96,140 | +21.2% | 0.13% | +10.3% |
| Q2 2014 | $1,839,000 | +1.0% | 79,306 | +3.4% | 0.12% | -7.2% |
| Q1 2014 | $1,821,000 | +8.1% | 76,670 | +4.5% | 0.12% | +6.8% |
| Q4 2013 | $1,685,000 | -30.7% | 73,384 | -28.8% | 0.12% | -33.1% |
| Q3 2013 | $2,433,000 | +11.5% | 103,025 | +6.4% | 0.18% | +6.1% |
| Q2 2013 | $2,183,000 | – | 96,813 | – | 0.16% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Adelphi Capital LLP | 8,958,784 | $176,757,000 | 33.75% |
| Ovata Capital Management Ltd | 879,800 | $17,557,092,000 | 13.04% |
| Paulson & Co. | 13,244,711 | $261,318,000 | 5.64% |
| Glenview Capital Management | 30,582,721 | $603,397,000 | 5.28% |
| MIC CAPITAL PARTNERS (PUBLIC) (US) IM, LLC | 718,028 | $14,167,000 | 4.85% |
| Velanne Asset Management Ltd | 302,694 | $5,972,000 | 3.52% |
| Blackcrane Capital, LLC | 172,708 | $3,408,000 | 2.72% |
| Melqart Asset Management (UK) Ltd | 1,557,000 | $30,720,000 | 2.57% |
| GMT CAPITAL CORP | 3,345,976 | $66,016,000 | 2.55% |
| REDWOOD CAPITAL MANAGEMENT, LLC | 827,955 | $16,336,000 | 2.24% |